Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This is a single-center, prospective, open label study in islet transplant recipients after
complete islet graft rejection/loss, defined as stimulated c-peptide ≤0.3 ng/mL.